
Solventum Corporation
SOLVNYSEHealthcareMedical - Instruments & Supplies
Previous close
$89.57
+$0.96 · +1.08%
SOLV company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
100
Deep Value
Momentum
42
Neutral
Sentiment
61
Bullish
Risk resilience
71
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteSolventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Bryan C. Hanson
- Listed since
- Apr 1, 2024
- Employees
- 20,584
Market position
Day range
Current $89.57
52-week range
Current $89.57
- Open
- $88.26
- Previous close
- $88.61
- Volume
- 730.81K
- 0.48× average
- Average volume
- 1.53M
- Average daily volume
- Market cap
- 15.51B USD
- Beta
- 0.67
- Market reference 1
- 50-day average
- $80.976
- +10.61% above average
- 200-day average
- $76.4198
- +17.21% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- P/E (TTM)
- 10.9×
- P/B (TTM)
- 3.24×
- P/S (TTM)
- 1.87×
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 54.69%
- Operating margin
- 24.99%
- Net margin
- 17.26%
Financial health
- Debt / equity
- 1.1×
Earnings
- EPS beat rate
- 100%
- 10 beats, 0 misses, 0 met estimates
- Average EPS surprise
- +12.85%
- 10 comparable reports
- Latest EPS result
- 2.55
- Estimate 1.9 · Beat by 34.21%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$91.22
1.84% upsideRecent analyst actions
SOLV news
SOLV peers
Continue in GoAI
Research SOLVresearch.disclaimer











